Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 206
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT07660796 | A Study to Evaluate Efficacy and Safety of HCP1803-4 in Patients With Essential Hypertension | ||
| NCT01452451 | Safety, Tolerability, Pharmacokinetics,Pharmacodynamics Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus | ||
| NCT05024721 | Study to Evaluate the Efficacy and Safety of HIP2101 in Patients With Acute or Chronic Gastritis | ||
| NCT04510415 | Olmutinib 600 mg QD in Patients With T790M-positive NSCLC After Treatment With an EGFR-TKI | ||
| NCT01514903 | Pharmacokinetics of Sildenafil Following Administration of an Chewable Tablet of Sildenafil Relative to Viagra® Conventional Oral Tablet in Healthy Volunteers | ||
| NCT04732416 | HM15136 (Efpegerglucagon) Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital Hyperinsulinism (CHI) | ||
| NCT04967014 | Study to Evaluate the Safety and Pharmacodynamic/Pharmacokinetic Characteristics of HIP2101 in Healthy Volunteers | ||
| NCT03684642 | Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin | ||
| NCT04032782 | A First-in-Human, Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HM15136(Efpegerglucagon) in Healthy Subjects | ||
| NCT03826641 | A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1801 in Healthy Subjects | ||
| NCT05155995 | A Study to Evaluate the Pharmacokinetics and Safety Between HCP2001 and Co-administration of Each Component in Healthy Volunteers | ||
| NCT01548157 | Clinical Trial to Evaluate the Effect on the Pharmacokinetic Characteristics of HCP1007 Capsule | ||
| NCT01640535 | Efficacy and Safety of Concomitant Montelukast Sodium and Levocetirizine Dihydrochloride in Perennial Allergic Rhinitis (PAR) Patients | ||
| NCT02390882 | A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With BPH | ||
| NCT06234397 | Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors | ||
| NCT01638286 | Study to Evaluate a Pharmacokinetic Drug Interaction Between Eperisone Hydrochloride and Aceclofenac in Healthy Male Subjects | ||
| NCT04324905 | Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of HIP1802 to HGP1705 in Healthy Volunteers | ||
| NCT04654702 | Observational Study to Evaluate Therapeutic Effectiveness and Safety of Monterizine Cap. | ||
| NCT05656092 | A Study to Evaluate the Effiacy and Safety of HIP0612 in Patients With Gastric Ulcer | ||
| NCT01504581 | Safety, Pharmacokinetic, Pharmacodynamic Study of LAPS-IFNa in Healthy Adult Subjects | ||
| NCT01505777 | Exploratory Clinical Study to Evaluate the Optimal Dosage of Mosapride and Probiotics in Irritable Bowel Syndrome Without Predominant Diarrhea | ||
| NCT03713684 | Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Alone or in Combination With Oral Antidiabetic Drug(s) | ||
| NCT04087525 | A Study to Evaluate the Pharmacokinetics and Safety of HIP1701 in Healthy Subjects | ||
| NCT03897868 | A Phase 2 Study to Assess Dose-response Relationship of HCP1803 in Patients With Essential Hypertension | ||
| NCT01901757 | Single-dose, 2-way Crossover Open Study to Evaluate the Food Effect on the PK of HCP1201 in Healthy Volunteers | ||
| NCT02140489 | Evaluating a Pharmacokinetic Drug Interaction Between Amlodipine/Losartan and Rosuvastatin | ||
| NCT01491217 | A Study of Oraxol® in Gastric Cancer Patients | ||
| NCT05481307 | A Study to Evaluate Pharmacokinetic/Pharmacodynamic Drug-drug Interaction and Safety/Tolerability Between RLD2202 and RLD2203 | ||
| NCT05487560 | An Observational Study to Evaluate the Incidence of MACCE According to Time Interval of Taking Medication in Patients With Acute Coronary Syndrome or Cerebral Infarction Who Received DAPT for the Secondary Prevention and Esomezol Cap for the Prevention of Gastrointestinal Bleeding | ||
| NCT04788290 | An Observational Study Assessing Effects in Patients With Combination Therapy With Raloxifene/Cholecalciferol | ||
| NCT04081844 | A Study to Evaluate the Pharmacokinetic and Pharmacodynamic Interactions Between HGP0904, HGP0608, and HCP1306 in Healthy Male Subjects. | ||
| NCT04768686 | FLX475 Combined With Pembrolizumab in Patients With Advanced or Metastatic Gastric Cancer | ||
| NCT04074551 | A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia | ||
| NCT01746771 | A Phase I-II Study of HM781-36B Combined With Paclitaxel and Trastuzumab in HER-2 Positive Advanced Gastric Cancer | ||
| NCT01864863 | To Compare the Pharmacokinetics of Traclear 62.5 mg Tablets and HGP1206 125mg 1 Tablet in Healthy Male Volunteers | ||
| NCT02941848 | Evaluate the Pharmacokinetics and Safety of HCP1306 and Co-administration of HGP0816, HGP1404 in Healthy Male Volunteers | ||
| NCT05845489 | Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION) | ||
| NCT03118817 | Expansion Study to Evaluate the Efficacy and Safety of HM95573 in BRAF, KRAS or NRAS Mutant Solid Cancers | ||
| NCT01830491 | Comparison of Effect & Safety of Clopidogrel Napadisilate With Clopidogrel Bisulfate in Coronary Artery Disease Patients | ||
| NCT01929070 | A Pilot Study to Evaluate the Pharmacokinetics of Omega-3 Between Rosuvastatin and Omega-3 Coadministration and HCP1007 | ||
| NCT01775579 | Evaluating a Pharmacokinetic Drug Interaction Between Metformin Hydrochloride and Rosuvastatin Calcium | ||
| NCT05862090 | A Study to Evaluate the Drug-drug Interaction and Safety of RLD2301 and RLD2007 in Healthy Volunteers | ||
| NCT01764087 | A Study of KX2-391 With Paclitaxel in Patients With Solid Tumors | ||
| NCT07219589 | A Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese Participants | ||
| NCT01869985 | Partial Replicated Crossover Clinical Study to Compare Pharmacokinectic Characteristics of Eperisone Hydrochloride and Aceclofenac With HCP1104 Treatment to Those of Co-administration of Eperisone Hydrochloride 50mg Tablet and Aceclofenac 100mg Tablet in Healthy Adult Male Volunteers | ||
| NCT05191563 | A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination of HCP1904 and Co-Administration of RLD2001-2 and RLD2006 Tablets in Healthy Subjects. | ||
| NCT04346862 | Evaluation the Effect of Acetyl-L-carnitine in Patients With Mild Cognitive Impairment Accompanied With Chronic Cerebrovascular Disease | ||
| NCT04044170 | Poziotinib in Patients With NSCLC Having EGFR or HER2 Exon 20 Insertion Mutation | ||
| NCT05723549 | A Study to Evaluate the PK, Safety and Tolerability of HCP1803. | ||
| NCT01555398 | Clinical Trial to Evaluate the Effect of Food on the Pharmacokinetic Characteristics of HIP0901 Capsule |
